Below you will find funding opportunities with target areas that may be leveraged by SPARC and activities sponsored by programs whose mission and/or goals closely align with those of SPARC: provide the scientific foundation necessary to pilot new and/or improved closed-loop neuromodulation devices and stimulation protocols to treat diseases and conditions through precise neural control of end-organ system function.
National Cancer Institute: Neural Regulation of Cancer
These funding opportunities solicit projects focused on understanding how the nervous system and the molecules secreted by the nervous system promote tumor progression and metastasis. This collaborative, transdisciplinary research, which explores both neuroscience and cancer elements together, will advance current understanding of the nervous system contribution to cancer and ultimately inform the prevention and treatment of non-central nervous system tumors.
NIH SBIR/STTR: Targeted SBIR/STTR Funding Announcements
These funding opportunities solicit a diverse range of data science, technology and biology projects that may be of interest to SPARC awardees, device partners, and potential applicants. The opportunities are supported by a number of NIH Institutes/Centers or parallel programs: Brain Research through Advancing Innovative Neurotechnolgies Initiative (BRAIN) and the Office of Research Infrastructure Programs (ORIP).
- PA-16-181: Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42)
- PA-16-180: Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44)
- PAR-15-091: BRAIN Initiative - Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44)
NIH HEAL Initiative: Pain Management - Translational Devices to Treat Pain Funding Announcements
These funding opportunities solicit projects to advance pain treatment through identification of targets and development of medical devices, regardless of the level of technological maturity, that target the nervous system to provide therapeutic, rehabilitative, or diagnostic capability. The goal of this collaborative trans-NIH effort is to advance treatment using credible neural targets for device-based interventions and/or diagnostics for pain, building upon the latest mechanistic knowledge about the anatomy and physiology of central, spinal, and peripheral pathways involved in pain.
- RFA-EB18-003: HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
- RFA-NS18-042: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21, Clinical Trial Not Allowed)
- RFA-NS18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01, Clinical Trial Not Allowed)
- RFA-NS19-016: HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
- RFA-NS19-017: HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
- RFA-NS19-018: HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Conferences, Meetings and Workshops
International Society for Autonomic Neuroscience (ISAN) 2019
July 25-27, 2019
Los Angeles, CA
This page last reviewed on January 3, 2019